GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $635,000 | +38.9% | 26,569 | -15.1% | 0.00% | 0.0% |
Q4 2020 | $457,000 | +2.9% | 31,299 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $444,000 | -3.5% | 31,299 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $460,000 | +322.0% | 31,299 | +18.6% | 0.00% | – |
Q1 2020 | $109,000 | -14.8% | 26,385 | -0.7% | 0.00% | – |
Q4 2019 | $128,000 | -20.5% | 26,565 | 0.0% | 0.00% | – |
Q3 2019 | $161,000 | -6.4% | 26,565 | 0.0% | 0.00% | – |
Q2 2019 | $172,000 | -8.5% | 26,565 | 0.0% | 0.00% | – |
Q1 2019 | $188,000 | +45.7% | 26,565 | 0.0% | 0.00% | – |
Q4 2018 | $129,000 | -33.8% | 26,565 | 0.0% | 0.00% | – |
Q3 2018 | $195,000 | +15.4% | 26,565 | 0.0% | 0.00% | – |
Q2 2018 | $169,000 | +16.6% | 26,565 | 0.0% | 0.00% | – |
Q1 2018 | $145,000 | +30.6% | 26,565 | 0.0% | 0.00% | – |
Q4 2017 | $111,000 | -56.6% | 26,565 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $256,000 | -18.5% | 26,565 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $314,000 | +42.7% | 26,565 | +54.9% | 0.00% | 0.0% |
Q1 2017 | $220,000 | +4.8% | 17,147 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $210,000 | +4.0% | 17,147 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $202,000 | +36.5% | 17,147 | +0.8% | 0.00% | – |
Q2 2016 | $148,000 | +74.1% | 17,007 | +4.9% | 0.00% | – |
Q1 2016 | $85,000 | -32.5% | 16,208 | 0.0% | 0.00% | – |
Q4 2015 | $126,000 | +2.4% | 16,208 | +3.6% | 0.00% | – |
Q3 2015 | $123,000 | -6.8% | 15,648 | +7.8% | 0.00% | – |
Q2 2015 | $132,000 | -29.8% | 14,518 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $188,000 | -5.1% | 14,518 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $198,000 | +52.3% | 14,518 | 0.0% | 0.00% | – |
Q3 2014 | $130,000 | -33.7% | 14,518 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $196,000 | – | 14,518 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|